Australian medical cannabis company MMJ PhytoTech Limited has just sold its first marijuana pills. The bad news: They are only available in Europe.
The capsules were sold in August via a Swiss-based subsidiary, Satipharm. 10 milligrams of the medication will set you back 89 euros (A$139.95).
The pills are registered as a dietary supplement in Germany. Their active ingredient, Cannabidiol (CBD), is made from a special medical cannabis strain and they do not contain tetrahydrocannabinol (THC), the chemical that causes most of marijuana's psychological effects when smoked.
